Activity of pembrolizumab in relapsed/refractory NK/T-cell lymphoma

Natural killer/T-cell lymphoma (NKTCL) is a rare subtype of non-Hodgkin lymphoma that is associated with a poor outcome. Currently, the treatment needs of NKTCL remain unmet, and efforts to further improve treatment are urgently needed. Herein, seven patients with NKTCL who failed to respond to vari...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xin, Cheng, Yasong, Zhang, Mingzhi, Yan, Jiaqin, Li, Ling, Fu, Xiaorui, Zhang, Xudong, Chang, Yu, Sun, Zhenchang, Yu, Hui, Zhang, Lei, Wang, Xinhua, Wu, Jingjing, Li, Zhaoming, Nan, Feifei, Tian, Li, Li, Wencai, Young, Ken H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5793390/
https://www.ncbi.nlm.nih.gov/pubmed/29386072
http://dx.doi.org/10.1186/s13045-018-0559-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5793390/
https://www.ncbi.nlm.nih.gov/pubmed/29386072
http://dx.doi.org/10.1186/s13045-018-0559-7

Ejemplares similares